IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
IQVIA Holdings Inc.NYSE: IQV
Other Non-Cash Items · Q2 FY2026 · quarter ended Jun 2026
Other non-cash items growth accelerates
Q2 FY2026 other non-cash items of $17M (cash outflow) rose 70.0% year over year, ahead of the -7566.7% change in trailing-twelve-month other non-cash items.
Context
- Other non-cash items amounted to 0.3% of revenue in FY2025, up 0.2 pp from a year earlier.
- Other non-cash items increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +70.0% holds above the trailing-twelve-month pace of -7566.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- (43M) USD
- Year-over-year change
- -616.7%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (43M) | -616.7% |
| FY2024 | 2024-12-31 | (6M) | -200.0% |
| FY2023 | 2023-12-31 | (2M) | -104.5% |
| FY2022 | 2022-12-31 | 44M | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Non-Cash Items vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's LTM Jun 2026 other non-cash items of $224M is the 4th largest of the 9 companies compared; the peer median is $121.59M.
- Its year-over-year change of -7566.7% is the lowest of 9, against a peer median of +23.6%.
- Other non-cash items amounts to 1.3% of revenue for IQV, versus a peer median of 7.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $725.89M | +447.2% | +80.6% | 8.8% | |
| LTM Jun 2026 | $579.04M | +41.5% | — | 14.5% | |
| LTM Jul 2026 | $259.78M | -26.9% | -70.1% | 7.5% | |
| LTM Jun 2026 | $224M | -7566.7% | — | 1.3% | |
| LTM Mar 2026 | $215.76M | +13309.8% | +795.2% | 71.3% | |
| LTM Mar 2026 | $27.41M | +263.1% | — | 6.5% | |
| LTM Sep 2026 | $23.82M | +5.7% | +11.7% | 0.8% | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | $5.1M | -100.6% | +173.6% | 0.2% |
| LTM Sep 2026 | $709K | -96.9% | +17.1% | 0.0% | |
| Peer median (excluding IQV) | $121.59M | +23.6% | +48.8% | 7.0% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 966M | 1.09B | 1.36B | 1.37B | 1.36B |
| Depreciation & Amortization | 1.26B | 1.13B | 1.13B | 1.11B | 1.14B |
| Deferred Income Tax | (138M) | (115M) | (269M) | (129M) | (180M) |
| Stock-Based Compensation | 170M | 194M | 217M | 206M | 247M |
| Change in Working Capital | 680M | (84M) | (280M) | 158M | 125M |
| Accounts Receivables | (138M) | (421M) | (388M) | 182M | 60M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 244M | 427M | 267M | 115M | (96M) |
| Other Working Capital | 574M | (90M) | (159M) | (139M) | 161M |
| Other Non-Cash Items | 0 | 44M | (2M) | (6M) | (43M) |
| Operating Cash Flow | 2.94B | 2.26B | 2.15B | 2.72B | 2.65B |
| Capital Expenditures | (640M) | (674M) | (649M) | (602M) | (603M) |
| Acquisitions (Net) | (1.46B) | (1.34B) | (876M) | (710M) | (1.76B) |
| Purchases of Investments | (15M) | (5M) | (83M) | (134M) | (20M) |
| Sales of Investments | 5M | 0 | 0 | 0 | 2M |
| Other Investing Activities | 5M | 8M | 5M | 2M | 74M |
| Investing Cash Flow | (2.1B) | (2.01B) | (1.6B) | (1.44B) | (2.31B) |
| Debt Repayment | 70M | 941M | 802M | 553M | 1.21B |
| Common Stock Issued | 0 | 0 | 0 | 0 | (67M) |
| Common Stock Repurchased | (406M) | (1.17B) | (992M) | (1.35B) | (1.24B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (899M) | (102M) | (192M) | (81M) | (44M) |
| Financing Cash Flow | (1.24B) | (329M) | (382M) | (878M) | (150M) |
| Effect of Forex Changes | (52M) | (75M) | (4M) | (68M) | 79M |
| Net Change in Cash | (448M) | (150M) | 160M | 326M | 278M |
| Free Cash Flow | 2.3B | 1.59B | 1.5B | 2.11B | 2.05B |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.